Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:

Postmarket Surveillance Orders Expected To Follow Final Rule

This article was originally published in The Gray Sheet

  • News

Executive Summary

The Center for Devices and Radiological Health plans to issue new orders for postmarket surveillance in several device areas soon after issuing a final rule on the Safe Medical Devices Act Sec. 522 provision.

You may also be interested in...



"Real World" Data Required On Vascular Closure Devices, CDRH Advises

CDRH's Office of Surveillance and Biometrics plans to collaborate with Duke University's Center for Education and Research on Therapeutics (CERT) on a large population study of arteriotomy closure devices.

"Real World" Data Required On Vascular Closure Devices, CDRH Advises

CDRH's Office of Surveillance and Biometrics plans to collaborate with Duke University's Center for Education and Research on Therapeutics (CERT) on a large population study of arteriotomy closure devices.

AneuRx Is First Sec. 522 Study Ordered Under Proposed Rule; More To Follow

Medtronic's AneuRx abdominal aortic aneurysm (AAA) endovascular graft will aim to compare long-term outcomes of the device's IDE cohort with patients who received the implant postmarket.
Table

View full table

Related Content

Medtech Insight Medtech Insight Medtech Insight
Tags:
UsernamePublicRestriction

Register

MT014785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By